Big Gain For Protalix BioTherapeutics, Inc.
Mon, Nov 18, 2019 at 05:30 PM
Protalix BioTherapeutics, Inc. (PLX:NYSEMKT) jumped higher today at $0.26, representing a gain of 32.3%. On Fri, 15 Nov 19, PLX:NYSEMKT hit a New 2-Week Low of $0.2. The stock featured on our News Catalysts scanner on Mon, 18 Nov 19 at 07:21 AM. From Mon, 28 Oct 19, the stock recorded 21.43% Up Days and 6.67% Green Days
The stock spiked on Thu, 17 Oct 19 at $0.47 with a volume of 27M+.
The share price of the company has been moving sideways in recent weeks.
About Protalix BioTherapeutics, Inc. (PLX:NYSEMKT)
Protalix BioTherapeutics Inc is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system, or ProCellEx.
Top 10 Gainers:
- Karuna Therapeutics, Inc. (KRTX:NASDAQ), 442.99%
- Hermitage Offshore Services Ltd. (PSV:NYSE), 55.14%
- Evoke Pharma, Inc. (EVOK:NASDAQ), 34.55%
- Protalix BioTherapeutics, Inc. (PLX:NYSEMKT), 32.31%
- NovaBay Pharmaceuticals, Inc. (NBY:NYSEMKT), 29.78%
- BiomX Inc. (PHGE:NYSEMKT), 29.2%
- Standard Diversified Inc. (SDI:NYSEMKT), 27.64%
- Advaxis, Inc. (ADXS:NASDAQ), 26.57%
- Waitr Holdings Inc. (WTRH:NASDAQ), 26.28%
- Cyclacel Pharmaceuticals, Inc. (CYCC:NASDAQ), 26.1%